LCP Health Analytics presence at the ISPE 2025 Annual Meeting
Health analytics Real world evidence generation Life sciences
The 41st ISPE Annual Meeting took place at the Walter E. Washington Convention Center, between August 22 - 26, 2025. LCP Health Analytics presented our pioneering work at the leading conference for pharmacoepidemiology.
Hot topic debate
Over the past 18 months, LCP Health Analytics have been developing cutting-edge applications of generative AI for real-world evidence (RWE) and pharmacoepidemiology. At the ISPE Annual Meeting, we presented a plenary session about the merits and pitfalls of using LLMs in pharmacoepidemiology activities, and whether the field will change fundamentally as a result.
Dr Ben Bray, Evidence Generation Lead at LCP Health Analytics, was joined by expert panellists across industry, consultancy, and academia to answer the ultimate question: can LLMs perform pharmacoepidemiology tasks as well (or better than) humans?
Workshop presentations
Our team of specialists took part in a practical, in-depth workshop exploring ‘The Future of Pharmacovigilance: Accelerating Signal Identification with Electronic Healthcare Data’. Dr Ben Bray, Evidence Generation Lead, was joined by panellists from industry, regulation, and academia to explore how to augment existing pharmacovigilance systems with novel approaches utilizing electronic healthcare data records.
Our team presented 10 posters on hot topics including drug-gene interactions, harmonizing standards in RWE, and pregnancy drug safety studies. You can find all topics here as well as access to three posters we presented. To discuss any topic, please contact us.
|
Poster title |
Authors |
|
A fully automated AI-enabled pipeline for extracting Kaplan-Meier survival data from scientific plots Explore the poster |
|
|
Comparison of Primary Care Coded Prevalence of Atrial Fibrillation and Prescribing Rates for Drugs Indicated for Atrial Fibrillation Identified Using a Large-Language Model Explore the poster |
|
|
Prevalence of Drug-Gene Interactions Following Acute Myocardial Infarction: An Observational Study Using Data From the UK Biobank Explore the poster |
|
|
An evidence base to support the establishment of a fit-for-purpose quality management system for secondary data pharmacoepidemiological studies |
|
|
Assessing core competencies in pharmacoepidemiology training programs: A Global Needs Assessment |
|
|
Assessing the association between COVID-19 Vaccination and Thrombotic Thrombocytopenia Syndrome (ATTEST Study): Analysis of English Data 2020-2022 |
|
|
Enhancing Pregnancy Drug Safety Studies: Expert Consensus on Methods and Definitions |
|
|
Harmonizing Standards: Recommendations for Mitigating Gaps in Real-World Evidence (RWE) Feasibility Guidance |
|
|
Risk of Venous Thrombosis with Thromboocytopenia Syndrome after vaccination with AZD1222: A European VAC4EU Post-authorisation Safety Study |
|
|
Safety Profile of Vaxzevria COVID-19 Vaccine in the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER) |
|
Want to find out more about the work we presented?
Please look take a look at case studies that showcase our work in RWE, and get in touch.
LCP Health Analytics partners with COTA to advance the use of US RWD to support HTA decision making internationally
Read nowThe associations between multimorbidity, healthcare resource utilisation and costs in individuals with Alzheimer's disease dementia
Read nowIncreasing comorbidities in patients with type 2 diabetes and implications for total morbidity and health system impacts health analytics life sciences
Read nowSubscribe to our thinking
Get relevant insights, leading perspectives and event invitations delivered right to your inbox.
Get started to select your preferences.
